Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women
Ross L. Prentice(Fred Hutch Cancer Center), Garnet L. Anderson(Fred Hutch Cancer Center), F. Allan Hubbell(University of Wisconsin–Madison), Jacques E. Rossouw(Baylor College of Medicine), Dorothy S. Lane(Stony Brook School), Marcia L. Stefanick(Stanford University), Mary Pettinger(Fred Hutch Cancer Center), Lewis H. Kuller(University of Minnesota), Anne McTiernan(Fred Hutch Cancer Center), Susan L. Hendrix(University at Buffalo, State University of New York), M.J. O’Sullivan(University of Miami), Charles Kooperberg(Fred Hutch Cancer Center), JoAnn E. Manson(Brigham and Women's Hospital), Rowan T. Chlebowski(The Ohio State University)
Cited by 140
Related Papers
A reference panel of 64,976 haplotypes for genotype imputation
|Nature Genetics|2016|3.3k
Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
|JAMA|2007|1.7k
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
|Nature Genetics|2012|1.2k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Effects of Aerobic Exercise on Mild Cognitive Impairment
|Archives of Neurology|2010|1.2k